[Translated article] Longitudinal Study of Different Progression Patterns in High-Risk Cutaneous Squamous Cell Carcinoma

被引:0
|
作者
Tejera-Vaquerizo, A. [1 ,2 ]
Canueto, J. [3 ]
Gomez-Tomas, A. [4 ]
Santos-Juanes, J. [5 ]
Ribero, S. [6 ]
Avallone, G. [6 ]
Jaka, A. [7 ]
Ferrandiz-Pulido, C. [4 ]
Toll, A. [8 ]
Sanmartin, O. [9 ]
机构
[1] Hosp San Juan Dios, Unidad Oncol Cutanea, Cordoba, Spain
[2] Inst Dermatol GlobalDerm, Serv Dermatol, Palma Del Rio, Cordoba, Spain
[3] Complejo Asistencial Univ Salamanca, Serv Dermatol, Salamanca, Spain
[4] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Dermatol, Barcelona, Spain
[5] Univ Oviedo, Hosp Cent Asturias Inst Invest Sanitaria Principad, Serv Dermatol, IUOPA, Oviedo, Spain
[6] Univ Turin, Med Sci Dept, Sect Dermatol, Turin, Italy
[7] Univ Autonoma Barcelona, Hosp Univ Germans Trials & Pujol, Inst Invest Germans Trias & Pujol, Serv Dermatol, Badalona, Barcelona, Spain
[8] Univ Barcelona, Hosp Clin, Serv Dermatol, Barcelona, Spain
[9] Inst Valenciano Oncol, Serv Dermatol, Valencia, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2024年 / 115卷 / 07期
关键词
Cutaneous squamous cell carcinoma; Prognosis; Neoplastic metastasis; Lymphatic metastasis; Disease progression; CANCER METASTASIS; NODE BIOPSY; LYMPHADENECTOMY;
D O I
10.1016/j.ad.2024.05.016
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and objective: Cutaneous squamous cell carcinoma (cSCC) is the second leading cause of skin cancer mortality in Europe. Few studies have analyzed the different pathways of this tumor progression in its natural history. The main objective of this study was to analyze the different metastatic and progression pathways and their temporal occurrence in the evolution of cSCC. Material and method: We conducted a multicenter, retrospective, and observational study of consecutive high -risk sSCCs included in the SQUAMATA project. Results: A total of 222 out of the 1346 patients included relapsed. The most frequent route of progression was the lymphatic one (62.6%). A total of 20.2% of the cases with lymphatic progression developed distant metastases. Only 1 case (3.1%) of distant metastasis followed local recurrence without previous lymphatic metastasis. The median time to disease -related mortality was longer in patients who developed systemic metastases than in those who died of locoregional progression.
引用
收藏
页码:T670 / T678
页数:9
相关论文
共 50 条
  • [41] 40-Gene expression profile test predicting metastatic risk in localized, high-risk cutaneous squamous cell carcinoma for peer review
    Samman, Luna
    Fernandez, Chloe
    Gomez-Meade, Carlos
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
  • [42] Clinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ: A Retrospective Double-cohort Study
    Knuutila, Jaakko S.
    Kaijala, Olli
    Lehto, Salla
    Vahlberg, Tero
    Nissinen, Liisa
    Kahari, Veli-Matti
    Riihila, Pilvi
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [43] Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas
    Maher, Jacqueline M.
    Schmults, Chrysalyne D.
    Murad, Fadi
    Karia, Pritesh S.
    Benson, Carol B.
    Ruiz, Emily Stamell
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) : 920 - 926
  • [44] Prospective Randomized Study on the Use of Sentinel Node Biopsy for High-risk Cutaneous Squamous Cell Carcinomas of the Head and Neck
    Spyropoulou, Georgia-Alexandra
    Mpalaris, Vassilis
    Pervana, Stavroula
    Trakatelli, Myrto
    Foroglou, Periklis
    Milothridis, Panagiotis
    Garoufalias, Theodoros
    Drougou, Avra
    Demiri, Efterpi
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2024, 12 (08) : e6092
  • [45] Detection of the high-risk factors for synchronous bone metastasis in tonsillar squamous cell carcinoma
    Yujiao Li
    Chaosu Hu
    European Archives of Oto-Rhino-Laryngology, 2023, 280 : 4619 - 4625
  • [46] High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: Risk Factors for Recurrence and Impact of Adjuvant Treatment
    Trosman, Samuel J.
    Zhu, Angela
    Nicolli, Elizabeth A.
    Leibowitz, Jason M.
    Sargi, Zoukaa B.
    LARYNGOSCOPE, 2021, 131 (01) : E136 - E143
  • [47] Detection of the high-risk factors for synchronous bone metastasis in tonsillar squamous cell carcinoma
    Li, Yujiao
    Hu, Chaosu
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (10) : 4619 - 4625
  • [48] Patterns of Failure After Trimodal Treatment in Esophageal Squamous Cell Carcinoma: Initial Experiences from a High-Risk Endemic Area
    Ahmad, Sheikh Zahoor
    Battoo, Azhar Jan
    Haji, Altaf Gauhar
    Naveed, Shah
    Qurieshi, Mariya Amin
    Mir, Abdul Wahid
    Malik, Tariq Rasool
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2020, 11 (03) : 360 - 366
  • [49] Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma
    Litchman, Graham H.
    Fitzgerald, Alison L.
    Kurley, Sarah J.
    Cook, Robert W.
    Rigel, Darrell S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (08) : 1295 - 1300
  • [50] Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma
    Khandelwal, Alok R.
    Kent, Burton
    Hillary, Savage
    Alam, Md Maksudul
    Ma, Xiaohua
    Gu, Xin
    DiGiovanni, John
    Nathan, Cherie-Ann O.
    MOLECULAR CARCINOGENESIS, 2019, 58 (10) : 1715 - 1725